Trilantic North America, a growth-focused middle market private equity firm, has invested in Sofie Biosciences, a founder-led radiopharmacy and contract development and manufacturing organization.
The investment was made in partnership with Sofie's founding team, who will retain an equity stake and continue to lead the business. The firm said that this growth investment will capitalize on several growth initiatives, including expanding capacity and points of presence to improve patient access to Sofie's growing portfolio of radiopharmaceutical products.
William Blair & Company acted as financial advisor and Kirkland & Ellis provided legal advice to Trilantic North America. Solomon Partners Securities acted as financial advisor and Paul, Weiss, Rifkind, Wharton & Garrison provided legal services to Sofie.
